Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Concentriq, our advanced AI-driven software platform, operates at the crucial crossroads of digital and computational pathology, merging essential functionalities for routine pathology tasks with robust AI tools that enhance innovations and elevate patient care quality. Pathology laboratories around the globe are acutely aware of the contemporary hurdles, which include an escalating cancer incidence, a shortage of trained pathologists, diminishing reimbursement rates, and the urgent need for modernization. In this context, with one billion pathology slides projected to transition to digital formats annually, generating enormous volumes of new data and insights, the urgency to act is undeniable. Digital pathology equips today’s progressive pathology organizations with the resources necessary to tackle these challenges effectively, thereby revolutionizing our operational methods and significantly impacting the fields of medicine and patient treatment. As this transformation unfolds, the potential for improved diagnostics and enhanced patient outcomes continues to grow exponentially.

Description

By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

Signals Research Suite

Integrations

Signals Research Suite

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Proscia

Founded

2014

Country

United States

Website

proscia.com

Vendor Details

Company Name

PerkinElmer

Founded

1937

Country

United States

Website

perkinelmerinformatics.com/products/clinical-translational/signals-translational/

Product Features

Product Features

Alternatives

Alternatives

Signals Research Suite Reviews

Signals Research Suite

PerkinElmer Informatics
The Galen Platform Reviews

The Galen Platform

Ibex Medical Analytics
Signals Inventa Reviews

Signals Inventa

PerkinElmer Informatics
OneLABz Reviews

OneLABz

TechXect
Kanteron Reviews

Kanteron

Kanteron Systems